Rasmussen, Louise M <br/><br/>
A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Dec 2007 
 - 191-203 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6806 
<br/><br/><label>Standard No.: </label>10.1007/s10549-007-9494-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Binding, Competitive<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--pharmacology<br/>Estradiol--analogs & derivatives<br/>Estrogen Receptor Modulators--chemistry<br/>Fulvestrant<br/>Humans<br/>Ligands<br/>Norpregnatrienes--chemistry<br/>Receptors, Estrogen--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Selective Estrogen Receptor Modulators--pharmacology<br/>Steryl-Sulfatase--antagonists & inhibitors<br/>Tamoxifen--pharmacology<br/>Tumor Cells, Cultured--drug effects